ru 58841 has been researched along with cyproterone acetate in 3 studies
| Studies (ru 58841) | Trials (ru 58841) | Recent Studies (post-2010) (ru 58841) | Studies (cyproterone acetate) | Trials (cyproterone acetate) | Recent Studies (post-2010) (cyproterone acetate) |
|---|---|---|---|---|---|
| 25 | 0 | 4 | 1,845 | 339 | 261 |
| Protein | Taxonomy | ru 58841 (IC50) | cyproterone acetate (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 0.225 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.225 | |
| Androgen receptor | Homo sapiens (human) | 0.1408 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.339 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.225 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.225 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.225 | |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.045 | |
| Mu-type opioid receptor | Homo sapiens (human) | 2.183 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaillard, M; Matias, JR | 1 |
| Chang, C; Miyamoto, H; Wilding, G; Yeh, S | 1 |
| Blaschke, T; Kleuser, B; Korting, HC; Kramer, KD; Mehnert, W; Schäfer-Korting, M; Seltmann, H; Sivaramakrishnan, R; Stecová, J; Zouboulis, CC | 1 |
3 other study(ies) available for ru 58841 and cyproterone acetate
| Article | Year |
|---|---|
Local inhibition of sebaceous gland growth by topically applied RU 58841.
Topics: Administration, Topical; Androgen Antagonists; Animals; Cricetinae; Cyproterone Acetate; Ear; Imidazoles; Indenes; Male; Mesocricetus; Models, Biological; Nitriles; Sebaceous Glands; Structure-Activity Relationship; Time Factors | 1995 |
Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells.
Topics: Androgen Antagonists; Androgens; Anilides; Cyproterone Acetate; Drug Interactions; Flutamide; Humans; Imidazoles; Male; Mifepristone; Nitriles; Nuclear Receptor Coactivators; Oncogene Proteins; Prostatic Neoplasms; Protein Binding; Protein Conformation; Tosyl Compounds; Trans-Activators; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured | 1998 |
Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake.
Topics: Acne Vulgaris; Administration, Cutaneous; Androgen Antagonists; Cell Proliferation; Cell Survival; Cells, Cultured; Cyproterone Acetate; Drug Compounding; Drug Stability; Drug Storage; Fibroblasts; Gene Expression; Humans; Imidazoles; In Vitro Techniques; Keratinocytes; Lipids; Microspheres; Nanoparticles; Nitriles; Particle Size; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Skin; Temperature; Time Factors | 2007 |